People: Zynerba Pharmaceuticals Inc (ZYNE.OQ)

ZYNE.OQ on NASDAQ Stock Exchange Global Market

1:30am IST
Change (% chg)

$-1.33 (-7.15%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Rosenberger, Brian 

Mr. Brian Rosenberger serves as Vice President - Commercial of the Company. He served as our vice president, commercial since January 2017. Prior to joining our company, Mr. Rosenberger served as vice president, alliance and strategic portfolio management of Cipher Pharmaceuticals, Inc., a specialty pharmaceutical company, from May 2015 to January 2017, where he managed Cipher's global portfolio. From 2008 to April 2015, Mr. Rosenberger served in various roles at Auxilium, culminating in his role as executive director, corporate development and alliance management, where he participated in M&A, licensing and co-promotion deals through and including the acquisition of Auxilium by Endo International plc in January 2015. Prior to joining Auxilium, Mr. Rosenberger held sales managerial positions at Neurocrine Biosciences, Inc., a biopharmaceutical company, during the initial commercial build-out of the organization and spent over a decade at GlaxoSmithKline plc in various U.S. and global commercial roles within specialty markets, including neurohealth epilepsy marketing. Mr. Rosenberger holds a B.A. from Dickenson College.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --